Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
about
Sumatriptan (oral route of administration) for acute migraine attacks in adultsOral sumatriptan for acute migraineOral sumatriptan for acute migraineAcetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialAdvances in pharmacological treatment of migraineEFNS guideline on the drug treatment of migraine - report of an EFNS task forceHow does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.Providing relief from headache pain. Current options for acute and prophylactic therapy.Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.Acute migraine treatment outcome measures: a clinician's view.Drug comparisons: why are they so difficult?Evidence-based analysis of a migraine treatment drug comparison trial.The triptan formulations: a critical evaluation.Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel groRizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of lifeEfficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.Headache recurrence as a criterion for assessing efficacy of triptans: a perspective.Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.Migraine and its treatment with 5-HT1B/1D agonists (triptans).Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.Triptans and chest symptoms: the role of pulmonary vasoconstriction.Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacksA review of evidence-based medicine and meta-analytic reviews in migraine.Treatment-emergent CNS symptoms following triptan therapy are part of the attack.Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.Comparative tolerability of treatments for acute migraine: A network meta-analysis.Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.Comparison of expected outcomes between patients and neurologists using Kano's methodology in symptomatic migraine treatment.The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled paraTotal migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg.
P2860
Q24203707-95C19BFA-6618-4CFF-84C5-FF289FAD2277Q24203742-9D110ED6-533C-4260-86B2-79B0A25C2D55Q24248078-D271A0F5-674A-454E-9438-DBDE2730710DQ28188328-3D291D06-166D-4B35-AD3A-F9CF0D675963Q28192002-882710E6-64F5-485F-AEFE-62A3817ACAA2Q28219436-D32F8407-CA0A-4F31-95A9-D6CE5E83C6AFQ30692301-405611A8-751A-4897-AC77-FBBA64F5C2A8Q30831647-48B542EC-A0EB-4FBD-8D7E-7E3E93497E57Q33938046-545E6071-DE1D-44B9-9952-A3E964A2B756Q34044773-D69B2BD6-E47B-4974-9A49-D0514411EE68Q34154647-9E53E79F-1D3F-447E-92EA-A54012986391Q34155942-804E3B4B-F156-4346-ACB1-A8B2A9D6E3A7Q34155949-D8A86CBF-89D8-43EB-A077-E7B483413750Q34155953-D659016A-0FA0-4412-804E-C60EA13955ADQ34205890-DC9E02E8-8415-4233-BBFA-77EEEFEED9ADQ34566527-37DDB46A-3E1E-4933-AE3D-CEEE9E9BAC8EQ34581061-5522F687-6F19-4306-99E2-E14453BCAEA0Q34614148-0A2C1B99-C4CE-466F-99F4-528DB57FEF10Q34618466-B5586905-0F33-488E-A3C3-B0053D5CEFD9Q34634351-473EC84D-8FBD-45FD-8336-856F5F7DB0E0Q34691359-A2B69276-5FA6-437B-8653-71998A7F830FQ34873166-12F13937-4DFF-4F16-A80A-09CE2006EB16Q35091964-ECB73568-59F0-469D-AC45-BE5C8C1089E3Q35688196-48EC2D35-5028-4C11-8099-917F9F45BBFCQ35696691-77E35AED-FA9F-4C5C-8EB3-C20B9A92EC0DQ36013751-6B3D5174-FBDF-453D-B6D6-9D5B79C783A7Q36380205-67EA9709-DD0E-40A4-B21A-8A44A504BEE4Q36632277-F4B4FE44-F44A-4190-8DC1-EBAB879A6A56Q36768331-BCDD3C33-06B2-4663-8680-EB5AEB12C68DQ38066258-2217501F-93DB-4DB7-9B52-E6B95AA9FDD3Q38927015-A676C2B7-ADC9-4184-AE81-B861A895A19CQ39155775-7A6CA5B0-D41D-48EA-9F85-3CF0834309ECQ39249178-CFB41A1E-5D7A-4E16-A86F-6E4331E4D8E8Q39259551-1FEDC8FE-F54F-4122-B72D-66AE2ED1B7BAQ39277602-5DBF4120-223F-4E40-8480-E294FFB12C37Q39307655-C569EDB9-DDDC-4844-A202-60E4AA71653EQ39363107-6B353E99-6310-4B1D-A005-0262524820ECQ39375725-0D745FB4-8A65-43A2-8C9A-6F228DEFFE01Q39379584-82F94796-4672-4BE5-9F2F-BFE4B0C7E6C1Q39384899-EBB762C2-B0EA-4D61-A9E6-643F0B7EC953
P2860
Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@en
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@nl
type
label
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@en
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@nl
prefLabel
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@en
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@nl
P2093
P1433
P1476
Crossover comparison of rizatr ...... ptan Protocol 046 Study Group.
@en
P2093
Goldstein J
P304
P356
10.1046/J.1526-4610.1998.3810737.X
P577
1998-11-01T00:00:00Z